Loading...
Ligand Pharmaceuticals, Inc.
LGNDZ•PNK
Healthcare
Medical - Pharmaceuticals
$0.003
$-0.00(-7.41%)
Ligand Pharmaceuticals, Inc. (LGNDZ) Company Profile & Overview
Explore Ligand Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Ligand Pharmaceuticals, Inc. (LGNDZ) Company Profile & Overview
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOTodd C. Davis
Contact Information
555 Heritage Drive, Jupiter
Company Facts
68 Employees
CountryUS
Actively Trading